Home About Us Contact Us

Official Journals By StatPerson Publication

Table of Content Volume 13 Issue 1 - January 2020



.

Psychiatric morbidity in patients suffering from psoriasis attending tertiary care hospital

 

Ramya Keerthi Paradesi1, B Mounica2*, Nageswara Rao Nallapaneni3

 

1Assistant Professor, 2Post Graduate, 3Professor, Department of Psychiatry, Sri Venkateswara Medical College, Tirupati, Andhra Pradesh, INDIA.

Email: pramyakeerthi@gmail.com, mounikabharadwaj@gmail.com

 

Abstract               Background: Psoriasis is a chronic, relapsing and disfiguring dermatological disorder associated with various Psychiatric comorbidities which can further worsen it. There is a dearth of studies regarding this field, thus there is need to recognise Psychiatric comorbidities and treat them in these patients. Aim and Objective: The study was conducted to assess the psychiatric morbidity and their prevalence amongst psoriasis patients. Methodology: Sixty consecutive clinically diagnosed patients of psoriasis were interviewed by “Mini International Psychiatric Interview (MINI)” for screening Psychiatric morbidity in Psoriaisis patients and ICD-10 criteria were used to confirm the diagnosis. Results: Our study found an overall prevalence of psychiatric morbidities of 73.33% (n=44) in patients of psoriasis. In our present study, the distribution of specific psychiatric morbidities was as follows depressive disorder 44.93% {31.66% mild depression,13.33% moderate depression,} Anxiety disorders 20.01 % (GAD 8.34%, 6.67% panic disorder, 4.99% social phobia) alcohol dependence in 8.34%. A statistically significant association was found between marital status (p value: 0.044) and comorbid psychiatric diagnosis in patients of psoriasis. No significant association was found between other sociodemographic variables and comorbid psychiatric diagnosis. Conclusion: Psoriasis contributes to a great deal of psychiatric co-morbidity. Depression is the most common psychiatric morbidity in psoriasis Hence psoriasis patients must undergo psychiatric evaluation for better outcome of psoriasis management.

Key Words: Psoriasis, Psychiatric co-morbidity, MINI, Depression, Anxiety, Alcohol dependence.

 

INTRODUCTION

The Skin Plays A Key Role In The Socialization Processes Throughout The Life, And its Appearance Greatly Influences Body Image And Self-esteem. Psoriasis Is A Chronic Relapsing and Inflammatory Skin Disease that is immune-mediated and genetically determined, and Presents With Erythematous, Scaling Papules And Indurated Plaques, Arising Mainly On The Elbows, Knees, Scalp1. Patients With Psoriasis Can Feel Embarrassed By Their Appearance, Leading To Low Body Image And Low Self-esteem. Furthermore, May Feel Socially Stigmatized And Excluded2. Psychiatric morbidity in psoriasis is a psychiatric disorder associated with psoriasis because of the disease. The presence of itching, chronic recurrent course of the disease, and incomplete cure are the factors that contribute to a great deal of psychiatric morbidity in the patients who have psoriasis.3 The data on the prevalence of psychiatric morbidity in psoriasis among patients of psoriasis varies from 26.25% to 95% in previous studies done abroad.4 Indian studies reported psychiatric morbidity ranging from 32.33% to 84%5,6 There is a dearth of studies regarding this field, thus there is need to recognise Psychiatric comorbidities and treat them in these patients. Our study aimed to measure the prevalence of psychiatric morbidity.

 

 

MATERIALS AND METHODS

The study was conducted by Department of Psychiatry, Sri Venkateswara medical college, Andhra Pradesh, India. It was an Observational cross-sectional study. The study protocol was approved by Institutional ethics committee and the study period was 6 months. All consecutive patients of Psoriasis aged 18-64 years attending Dermatology OPD, were considered for the study. Those suffering from Co-morbid medical illness causing psychiatric morbidities like diabetes mellitus, hypertension, CVA and thyroid dysfunction were excluded from the study. Total 60 patients were included in study and a written informed consent was obtained from them. A Semi structured proforma was used to record the socio demographic data. The tools used were socio demographic data, and the MINI – International Neuro Psychiatric Interview Scale for screening Psychiatric morbidity in Psoriaisis patients and ICD-10 criteria were used to confirm the diagnosis. The collected data analysed after the end of the study and statistical analysis was done with the help of Statistical Package for Social Sciences (SPSS).


 

RESULTS


Table 1: Distribution of Sociodemographic Variables in Patients of Psoriasis

VARIABLE

SUBVARIABLE

 

 

age in years

observed

percentage

<30

28

46.67

>30

32

53.33

total

60

100

gender

male

42

70.00%

female

18

30.00%

total

60

100.00%

marital status

married

42

70.00%

unmarried

16

26.67%

 

divorced

2

3.33%

total

60

100.00%

occupation

employed

46

76.67%

unemployed

14

23.33%

total

60

100.00%

socioeconomic status

upper

3

5.00%

upper middle

9

15.00%

lower middle

16

26.67%

upper lower

26

43.33%

lower

6

10.00%

total

60

100.00%

 

Table 2: Distribution of comorbid Psychiatric diagnosis in patients of Psoriasis

Psychiatric morbidity

Yes

44

73.33%

No

16

26.67%

Total

60

100.00%

 

Table 3: The distribution of Specific psychiatric morbidity in Psoriasis patients

Psychiatric diagnosis

Specific diagnosis

Number n

Percentage %

 

Depressive episode

Mild depressive episode

19

31.66

Moderate depressive episode

8

13.33

Total

27

Anxiety disorders

Generalized anxiety disorder

5

8.34

Social phobia

3

4.99

Panic disorder

4

8.34

Total

12

Alcohol use disorder

Alcohol dependence syndrome

5

6.67

Total

44

73.33

No psychiatric diagnosis

16

26.67%


Table 4: Correlation between Sociodemographic Variables and Comorbid Psychiatric

variables

Sub variables

With Psychiatric morbidity

With no psychiatric morbidity

Chi square

P value

age

Less than 30 years

40.9 %

62.5%

2.198

.138

 

More than 30 years

59.1%

37.5%

gender

Male

75.0%

56.3%

1.964

.161

Female

25.0%

43.8%

Marital status

Married

75.0%

56.3%

6.261

.044

 

Un married

25.0%

31.3%

 

Divorced

0.0%

12.5%

occupation

employed

72.7%

87.5%

1.431

.232

 

Un employed

27.3%

12.5%

Socio economic status

upper

2.3%

12.5%

8.416

.077

Upper middle

9.1%

31.3%

Lower middle

23.3%

3.3%

Upper lower

45.5%

37.5%

lower

11.4%

6.3%

A statistically significant association was found between marital status (p value: 0.044) and comorbid psychiatric diagnosis in patients of psoriasis. No significant association was found between other sociodemographic variables and comorbid psychiatric diagnosis.

 


DISCUSSION

The present study assessed the prevalence of psychiatric morbidity in psoriasis patients of a Tertiary Care Hospital, Tirupati, India. We also studied the impact of sociodemographic on psychiatric morbidity. Psoriasis in addition to the physical impact, has a significant effect on mental, emotional social functioning. Psoriasis is associated with different comorbidities such as metabolic abnormalities, cardiovascular disease and psychiatric disorders.24,25The chronic nature of the disease has a prominent negative influence on psychological and social well-being of the patient. Psychological distress has a significant and adverse effect on long term outcome in patients with psoriasis Hence it is also very essential to consider the psychiatric aspect of psoriasis. There is a two-peak age of onset for psoriasis; the first peak of onset is between 16–22 years, and the second peak of onset is between 57–60 years.28 In the present study, 42 patients were male, and 18 were female and 28 persons (46.6% ) were below 30 years of age and 32 persons (53.3 %) were above 30 years of age. The socio-cultural background of our country can explain the less number of females. The primary purpose of our present study was to study the prevalence of psychiatric disorders commonly associated with psoriasis. In our present study, psychiatric morbidity in the patients was 73.33% which was closer to previous studies done by Surendra Kumar et al.7 and Balasubramani et al. that reported 84 % and 66.7 %. Earlier studies by matto et al., Saleh et al., Picardi et al.6 ,11,14 reported psychiatric morbidity as 45%,24.27 %,38 %, respectively that were lower compared to our present study. In a study conducted by kashyap et al.17 Psychiatric morbidity was 43% which is quite low compared to our study. In our present study, the distribution of specific psychiatric morbidities was as follows depressive disorder -44.93% {31.66% mild depression, 13.33% moderate depression,} anxiety 20.01% (GAD 8.34%, 6.67 % panic disorder, 4.99% social phobia) alcohol dependence in 8.34%. The study by Deshpande et al.13 found depression among 50 -97 % of the patients which close to our findings. The study by SK. Mattoo et al.12 found the prevalence of depression was 30 % that was close to our study. Study by Sreelatha lakshmy et al.10and Kumar et al.7reported an overall prevalence of depression as 78.9 % and 90 % which are quiet high compared to our finding. A study conducted in Egypt by Wageeh Abdelnaser Hassana7reported a prevalence of depression of 76% which is high in contrast to our study. Prevalence of anxiety disorder In our present study is 20.0% which is in contrast to the study by Sree Latha Lakshmy et al.10which reported the prevalence of anxiety 76.7 %. Our finding was, in contrast, to study done by Saleh et al. Vivek mahta s.k Malhotra et al.11,15and who found the prevalence of GAD as 4% and 12% which are on the lower side compared to our study .study by manmeetsingh et al.19 found the prevalence of anxiety as 26.65 % which is close to our finding. In our present study prevalence of alcohol dependence is 5 % that is close to the findings of manmeetsingh et al. 19,28

 

CONCLUSION

Psoriasis contributes to a great deal of psychiatric co-morbidity. Depression is the most common psychiatric morbidity in psoriasis .this is in concordance with previous studies.Psychological distress has a significant and negative effect on long term management outcome in patients with psoriasisIf there is evidence of marked psychiatric morbidity, the patient should be seen by a psychiatrist. Psoriasis patients must undergo psychiatric evaluation for better outcome of psoriasis management

REFERENCES

  1. Gupta AK. Psychocutaneous disorders. In: Saddock B, Saddock V, Ruiz P, editors. Kaplan and Saddock’s Comprehensive Textbook of Psychiatry. 9th ed. Philadelphia, USA: 2009. p. 2423-4
  2. Kumar S, Kachhawha D, Das Koolwal G, Gehlot S, Awasthi A. Psychiatric morbidity in psoriasis patients: A pilot study. Indian J Dermatol Venereol Leprol. 2011;77:625.
  3. Langley RG, Krueger GG, Griffiths CE. Psoriasis: Epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005; 64 Suppl 2:ii1823
  4. Muammer S, Tuba A, Yelda K, Hamdi O. Psychiatric morbidity in dermatology patients: International Journal of Research in Medical Sciences | July 2016 | Vol 4 | Issue 7 Page 2527 Frequency and results of consultations. Ind J Dermatol. 2006;51:18-22.
  5. Wageeh Abdelnaser Hassana, Ahmed Abdelbaky Abdel-Rahmana, Psychiatric disorders among psoriatic patients attending Assiut University Hospital.Al-Azhar Assiut Med J 16:275–280 © 2019 Al-Azhar Assiut Medical Journal 1687-1693
  6. Mattoo SK, Handa S, Kaur I, Gupta N, Malhotra R. Psychiatric morbidity in Psoriasis: Prevalence and correlates in India. Ger J Psychiatry. 2005;8:17– 22
  7. Kumar S, Kachhawha D, Koolwal GD, Gehlot S, Awasthi A. Psychiatric morbidity in psoriasis patients: A pilot study. Indian J Dermatol Venereol Leprol. 2011;77:625
  8. Richards HL, Ray DW, Kirby B, Mason D, Plant D, Main CJ, Fortune DG, Griffiths CE. Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasis. Br J Dermatol. 2005;153:1114-20. 2
  9. Kashyap S et al. Int J Res Med Sci. 2016 Jul;4(7):2524-2527 International Journal of Research in Medical Sciences | July 2016 | Vol 4 | Issue 7 Page 2527 Frequency and results of consultations. Ind J Dermatol. 2006;51:18-22.
  10. Lakshmy, S., Balasundaram, S., Sarkar, S., Audhya, M., and Subramaniam, E. (2015). A Cross-sectional Study of Prevalence and Implications of Depression and Anxiety in Psoriasis. Indian journal of psychological medicine, 37(4), 434–440. doi:10.4103/0253-7176.168587
  11. Saleh HM, Salem SA, El Sheshetawy RS, El Samei AM. Comparative study of psychiatric morbidity and quality of life in psoriasis, vitiligo and alopecia areata. Egypt Dermatol Online J 2008;4:2.
  12. Kumar V, Mattoo SK, Handa S. Psychiatric morbidity in pemphigus and psoriasis: A comparative study from India. Asian J Psychiatr 2013;6:151 6
  13. Deshpande N, Desai N, Mundra VK. Psychiatric aspects of Psoriasis. Arch Indian Psychiatry 1998;4:61-4.
  14. Picardi A, Abeni D, Melchi CF. Psychiatric morbidity in dermatologic outpatients: An issue to be recognized. Br J Dermatol 2000;143:983-91.
  15. Vivek Mehta, S. K. Malhotra, Psychiatric evaluation of patients with psoriasis vulgaris and chronic urticaria. German J Psychiatry 2007; 10:104-110).
  16. Kadri N, Agoub M, Gnaoui SE, Berrada S, Moussaoui D. Prevalence of anxiety disorders: a population-based epidemiological study in metropolitan area of Casablanca, Morocco. Annual general psychiatry 2007; 6: 6.
  17. Kashyap S et al. Int J Res Med Sci. 2016 Jul;4(7):2524-2527
  18. Hanen MS, Samar AM, Rania S, Afaf MA. Comparative study of psychiatric morbidity and quality of life in psoriasis, vitiligo and alopecia areata. Egypt Dermatol Online J 2008; 4:45-51.
  19. Manmeet Singh1, Puneet Singh Soodan2, Avneet Kaur3, Hardev Singh SoodanStudy of Psychiatric Morbidity amongst Psoriasis Patients Attending Private Dermatology Centre4 2279-0853, p-ISSN: 2279-0861.Volume 14, Issue 10 Ver. II (Oct. 2015), PP 68-7
  20. Gowda S, Goldblum OM, McCall WV, Feldman SR. Factors affecting sleep quality in patients with psoriasis. J Am Acad Dermatol 2010;63:114-23
  21. Sunil Dogra, Savita Yadav. Psoriasis In India: Prevalence And Pattern. 2010;76:595-601
  22. El-Moselhy EA, Atlam SA, Mohammed AS, Hassan HM, Ebrahim AM. Psychosocial impact and quality of life among adult Egyptian patients with psoriasis. Dermatol Case Rep 2015; 1:2–9.
  23. Devrimici-Ozguven H, Kundakci N, Kumbaser H, Boyvat A. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol 2000;14:267-71.
  24. 3.Dimsdale JE, Irwin MR, Keefe PT, Stein MB. Stress and psychiatry.In: Saddock B, Saddock V, Ruiz P, editors. Kaplan and Saddock’Comprehensive Textbook of Psychiatry. 9th ed. Philadelphia, USA: 2009. p. 2407-8.
  25. Boehncke WH, Boehncke S, Tobin AM, Kirby B (2011b) The „psoriatic march“: a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol 20:303–307
  26. Gerdes S, Mrowietz U (2009) Impact of comorbidities on the management of psoriasis. Curr Probl Dermatol 38:21–36
  27. The prevalence of psoriasis in Denmark.F. Brandrup, A. Green Acta Derm Venereol. 1981; 61(4): 344–346.
  28. Rosa Parisi, Deborah P M Symmons, Christopher E M Griffiths and Darren M Ashcroft, Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence; Journal of Investigative Dermatology (2013) 133, 377–385.
  29. C. E. M. Griffiths and R. D. R. Barker, “Psoriasis. In: Rook- W. Wilkinsum Ebling,” Text book of dermatology, Last ed. Blackwell Science, 2004.
  30. Morse RM, Perry HO, Hurt RD. Alcoholism and psoriasis. Alcohol Clin Exp Res 1985; 9: 396–399.


Policy for Articles with Open Access
Authors who publish with MedPulse International Journal of Psychology (Print ISSN:2579-0919) (Online ISSN: 2636 - 459X) agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.